15 research outputs found
Tumor induction in mice locally irradiated with carbon ions:a retrospective analysis
Tumor induction in mice legs that were locally irradiated with carbon ions was compared to tumor induction by gamma rays after single and fractionated irradiation. A total of 250 tumors were induced in 1104 mice that received carbon-ion doses of 5 through 65 Gy. A total of 77 tumors were induced in 371 mice that received gamma-ray doses of 45 through 95 Gy. Of carbon-ion induced 91 tumors histologically examined, 97 percent was malignant, and sarcomas such as malignant fibrous histiocytoma (47%) and fibrosarcoma (32%) were most frequently observed. Malignant fibrous histiocytoma was also the most frequently observed tumor (12 out of 20 tumors; 60%) after gamma-ray irradiation, followed by carcinomas (25%) such as adenocarcinoma and squamous cell carcinoma. Neither dose fractionation nor linear energy transfer affected tumor induction for carbon ions and gamma rays. Dose responses were linear for carbon ions and gamma rays, and showed no saturation up to 65 Gy of carbon ions and 95 Gy of gamma rays. Relative biological effectiveness of carbon ions was 2.2 for tumor induction and 1.9 for early skin reaction. We conclude that risk of secondary tumor induction by carbon-ion radiotherapy would not be seriously higher than anticipated
Genomic instability of mutation induction in normal human fibroblast irradiated with chronically low-dose radiation in Heavy-ion radiation field
Genomic instability of mutation induction in normal human fibroblast irradiated with chronically low-dose radiation in Heavy-ion radiation field
Changes in the pharmacokinetics of Gd-DTPA in Experimental Tumors after Charged Particle Radiation: Comparison with gamma-ray Radiation
Cellular response in normal human cells exposed to chronically low-dose radiation in heavy-ion radiation field.
Cellular response in normal human cells exposed to chronically low-dose radiation in heavy-ion radiation field.
Cellular response in normal human cells exposed to chronically low-dose radiation in heavy ion radiation field.
Changes in the pharmacokinetics of Gd-DTPA in Experimental Tumors after Charged Particle Radiation: Comparison with gamma-ray Radiation
We performed dynamic MRI to reveal the characteristic gadopentetate dimeglumine (Gd-DTPA) uptake in carbon-ion irradiated tumor and compare it with photon irradiation. Fibrosarcomas in C3H mice legs were irradiated with either 16 Gy of carbon ions (74 keV/mm) or an equivalent dose (30 Gy) of Cs-137 gamma-rays. Dynamic MRI was performed 1 or 6 days after irradiation when the tumors showed an initial growth delay or incipient regrowth, respectively. The enhancement pattern was visualized by mapping the maximum enhanced time (Tmax), relative signal intensity maximum (SImax), and time delay of starting enhancement (Td). Significantly larger Tmax and Td values were observed in the tumors 1 day after carbon-ion irradiation than in the nonradiated tumors (No-R) and tumors 1 day after gamma-ray irradiation. Among the selected pixels in the tumors 6 days after carbon irradiation, 77% had Tmax values of less than 120 sec, significantly more than in the No-R group. The Tmax maps for the tumors irradiated with gamma-rays showed a similar tendency to the carbon-irradiated ones, and only a significant difference was obtained between tumors 1 and 6 days after irradiation. Tmax and Td in the carbon-ion irradiated tumors were different from those in the gamma-ray-irradiated tumors. These treatment-specific kinetics may be useful in predicting the therapeutic efficacy of carbon-ion treatment
Radioresistance of mouce gut crypt cells induced by fractionated irradiation with carbon ions
Europian Radiation Research 200